MedPath

Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery

Completed
Conditions
Epiretinal Membrane
Cataract Senile
Interventions
Procedure: Phacoemulsification, intraocular lens implant, vitrectomy.
Registration Number
NCT03045367
Lead Sponsor
Clinica Oculistica dell'Università di Torino
Brief Summary

This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • age > 55 years
  • visual acuity ≤ 20/40
  • idiopathic epiretinal membrane
  • cataract
  • Amsler test positive for metamorphopsia.
Exclusion Criteria
  • previous ocular interventions
  • other ocular diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
OutpatientsPhacoemulsification, intraocular lens implant, vitrectomy.Phacoemulsification, intraocular lens implant, vitrectomy.
Primary Outcome Measures
NameTimeMethod
MetamorphopsiaChange in metamorphopsia from baseline at 180 days.

Change in spatial degree of distortion perception

Area of central scotomaChange in area of central scotoma from baseline at 180 days

Change in area, in square pixel, of central scotoma

Visual AcuityChange in visual acuity from baseline at 180 days

Change in LogMAR visual acuity

Central fovea thicknessChange in fovea thickness from baseline at 180 days

Change in fovea thickness in µm at the Sd OCT

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath